ARQT
Arcutis Biotherapeutics, Inc. Common StockRecent alerts on ARQT
All signals →
News
Arcutis (ARQT) Stock Rises 31% in the Past Month: Here's Why - Zacks Investment Research
14d ago
News
FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma
14d ago
News
AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer
14d ago
News
FDA Expands argenx's (ARGX) Vyvgart Label to Treat Rare Disorder
14d ago
News
OVID Slumps 76% on Epilepsy Drug Failing Two Pivotal Studies
14d ago
News
Wall Street Analysts Think Arcutis Biotherapeutics (ARQT) Could Surge 99.89%: Read This Before Placing a Bet
14d ago
News
Viridian (VRDN) Up 10% on Clinical Updates for Eye Disease Drug
14d ago
News
Summit (SMMT) Stock Surges 57% in the Past Month: Here's Why
14d ago
News
FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D
14d ago
News
Avidity (RNA) Up 33% on Rare Muscle Disease Study Results
14d ago
News
AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
14d ago
News
Amgen's (AMGN) Uplizna Meets Study Goal for Rare Disease
14d ago
News
Agios (AGIO) Up 21% on Upbeat Data From 2nd Thalassemia Study
14d ago
News
Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data
14d ago
News
Agios (AGIO) Up 23% on Selling Brain Cancer Drug Royalty
14d ago
News
J&J's (JNJ) Oral Pill Improves Depression & Insomnia Symptoms
14d ago
News
Iovance (IOVA) Up 5% on Updated Data From Melanoma Study
14d ago
News
Merus (MRUS) Surges 36% on Head & Neck Cancer Antibody Data
14d ago
News
Moderna (MRNA) Stock Outperformed Industry YTD: Here's Why
14d ago
News
Pfizer (PFE) Starts Another Cost-Cut Plan to Save $1.5B by 2027
14d ago
News
Wall Street Analysts Believe Arcutis Biotherapeutics (ARQT) Could Rally 101.09%: Here's is How to Trade
14d ago
Insider trade
Sale by Latha Vairavan (SVP Chief Financial Officer)
19d ago
Insider trade
Sale by Patrick Burnett (Reporting Person's Title: EVP, Chief Medical Officer)
19d ago
News
Arcutis outlines $480M-$495M 2026 revenue guidance while expanding ZORYVE sales teams
26d ago
Insider trade
Sale by Masaru Matsuda (Reporting Person's title: EVP, Chief Legal Officer)
26d ago
Get push alerts for ARQT
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS